Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers

SIMPLE SUMMARY: While KRAS is a driver oncogene, tumor cells can acquire mutant KRAS independency by activating pathways that functionally substitute for mutant KRAS. These KRAS-independent tumor cells exhibit a mesenchymal phenotype, readily primed for potential metastasis. The activation of YAP an...

Descripción completa

Detalles Bibliográficos
Autores principales: Adachi, Yuta, Kimura, Ryo, Hirade, Kentaro, Ebi, Hiromichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533927/
https://www.ncbi.nlm.nih.gov/pubmed/34680229
http://dx.doi.org/10.3390/cancers13205081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533927/
https://www.ncbi.nlm.nih.gov/pubmed/34680229
http://dx.doi.org/10.3390/cancers13205081

Ejemplares similares